Targeted delivery combined with controlled drug release has a pivotal role in the future of
personalized medicine. This review covers the principles, advantages, and drawbacks of …

Antibody‐based cancer therapy, one of the most significant therapeutic strategies, has
achieved considerable success and progress over the past decades. Nevertheless …

Since the licensing of the first monoclonal antibody therapy in 1986, monoclonal antibodies
have become the largest class of biopharmaceuticals with over 80 antibodies currently …

Engineering natural macrophage cell membrane-camouflaged mesoporous silica
nanocapsules can reduce the arrested percentage of immune cells and tissues, effectively …

The overview covers the discovery of N-(2-hydroxypropyl) methacrylamide (HPMA)
copolymers, initial studies on their synthesis, evaluation of biological properties, and …

The tumor stroma in human cancers significantly limits the delivery of therapeutic agents into
cancer cells. To develop an effective therapeutic approach overcoming the physical barrier …

Hydrogels are crosslinked hydrophilic polymer structures that can imbibe large amounts of
water or biological fluids. Hydrogels are one of the upcoming classes of polymer-based …

The efficient and selective delivery of therapeutic drugs to the target site remains the main
obstacle in the development of new drugs and therapeutic interventions. Up until today …

We report a new thermal targeting method in which a thermally responsive drug carrier
selectively accumulates in a solid tumor that is maintained above physiological temperature …

The design, synthesis and properties of N-(2-hydroxypropyl) methacrylamide (HPMA)
copolymers as carriers of anticancer drugs are reviewed. Macromolecular therapeutics …